Hypertensive Disorders of Pregnancy and Long-Term Maternal Cardiovascular and Metabolic Biomarkers
American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e1976-e1981
DOI: 10.1055/a-2096-0443 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Ashley N Battarbee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Hauptthemen laut MEDLINE: Biomarkers, Hypertension, Pregnancy-Induced, Pre-Eclampsia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Objective
This study aimed to measure the association between hypertensive disorders of pregnancy (HDP) and long-term maternal metabolic and cardiovascular biomarkers. Study Design Follow-up study of patients who completed glucose tolerance testing 5 to 10 years after enrollment in a mild gestational diabetes mellitus (GDM) treatment trial or concurrent non-GDM cohort. Maternal serum insulin concentrations and cardiovascular markers VCAM-1, VEGF, CD40L, GDF-15, and ST-2 were measured, and insulinogenic index (IGI, pancreatic β-cell function) and 1/ homeostatic model assessment (insulin resistance) were calculated. Biomarkers were compared by presence of HDP (gestational hypertension or preeclampsia) during pregnancy. Multivariable linear regression estimated the association of HDP with biomarkers, adjusting for GDM, baseline body mass index (BMI), and years since pregnancy.
Results
Of 642 patients, 66 (10%) had HDP: 42 with gestational hypertension and 24 with preeclampsia. Patients with HDP had higher baseline and follow-up BMI, higher baseline blood pressure, and more chronic hypertension at follow-up. HDP was not associated with metabolic or cardiovascular biomarkers at follow-up. However, when HDP type was evaluated, patients with preeclampsia had lower GDF-15 levels (oxidative stress/cardiac ischemia), compared with patients without HDP (adjusted mean difference: −0.24, 95% confidence interval: −0.44, −0.03). There were no differences between gestational hypertension and no HDP.
Conclusion
In this cohort, metabolic and cardiovascular biomarkers 5 to 10 years after pregnancies did not differ by HDP. Patients with preeclampsia may have less oxidative stress/cardiac ischemia postpartum; however, this may have been observed due to chance alone given multiple comparisons. Longitudinal studies are needed to define the impact of HDP during pregnancy and interventions postpartum. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
- George Washington University Biostatistics Center, Washington, District of Columbia.
- Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
- Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah.
- Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas.
- Department of Obstetrics and Gynecology, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
ORCID-Profile: Ashley N Battarbee, Michael W Varner
Förderung
- NCATS NIH HHS
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Center for Advancing Translational Sciences
Zitieren
APA
Battarbee, A. N., Mele, L., Landon, M. B., Varner, M. W., Casey, B. M., Reddy, U. M., Wapner, R. J., Rouse, D. J., Thorp, J. M., Chien, E. K., Saade, G., Peaceman, A. M., Blackwell, S. C., & Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network (2024). Hypertensive Disorders of Pregnancy and Long-Term Maternal Cardiovascular and Metabolic Biomarkers. American Journal of Perinatology, 41(S 01 S 01), e1976-e1981. https://doi.org/10.1055/a-2096-0443
Vancouver
Battarbee AN, Mele L, Landon MB, Varner MW, Casey BM, Reddy UM, et al. Hypertensive Disorders of Pregnancy and Long-Term Maternal Cardiovascular and Metabolic Biomarkers. American Journal of Perinatology. 2024;41(S 01 S 01):e1976-e1981. doi:10.1055/a-2096-0443
BibTeX
@article{Battarbee2024,
author = {Battarbee, Ashley N and Mele, Lisa and Landon, Mark B and Varner, Michael W and Casey, Brian M and Reddy, Uma M and Wapner, Ronald J and Rouse, Dwight J and Thorp, John M and Chien, Edward K and Saade, George and Peaceman, Alan M and Blackwell, Sean C and Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network},
title = {Hypertensive Disorders of Pregnancy and Long-Term Maternal Cardiovascular and Metabolic Biomarkers},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {S 01 S 01},
pages = {e1976--e1981},
doi = {10.1055/a-2096-0443}
}
EUVIMED